SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-022188
Filing Date
2020-04-01
Accepted
2020-04-01 17:15:17
Documents
2
Period of Report
2020-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1569
2 POA DOCUMENT poa.txt EX-24.3_907698 3086
  Complete submission text file 0001209191-20-022188.txt   5961
Mailing Address
Business Address
BAILES JOSEPH S (Reporting) CIK: 0001201039 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38800 | Film No.: 20766278

Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)